Dubai, UAE- April 2025- The Pharmaceutical Research and Manufacturers Association Gulf (PHRMAG) commemorates its 20th anniversary, heralding two decades of fostering innovation, catalyzing policy discussion, and improving patient access to life-saving treatments across the Gulf. In keeping with the global spirit of World Health Day, this landmark moment underscores PHRMAG’s relentless efforts in instilling hope for the potential treatments and cures of the future.

Since its establishment in 2005, PHRMAG has grown into a trusted partner to healthcare regulators and stakeholders, representing 29 leading global biopharmaceutical companies. Through strategic collaboration, responsible advocacy, and unwavering commitment to ethical practices, PHRMAG continues to play a pivotal role in shaping the future of healthcare in the region.

Over the past 20 years, PHRMAG members have collectively contributed to key healthcare priorities in the Gulf region — including accelerating access to innovative therapies, fostering impactful public-private partnerships, and playing an active role in shaping policy and regulatory frameworks that support sustainable healthcare systems. These efforts have directly supported economies in the region to become a hub for healthcare excellence and biopharmaceutical advancement.

Also Read : PHRMAG appoints new Executive Committee for 2025–2027

Sameh Elfangary, Chairman of PHRMAG, commented: “As we celebrate this important milestone on World Health Day, we reflect with pride on the achievements of the past two decades — and more importantly, we look ahead with purpose. PHRMAG’s role as a trusted partner to the healthcare ecosystem continues to grow. We remain committed to fostering innovation, improving equitable access to transformative care, and supporting national ambitions for a future-ready healthcare system.”

Shahad Mahdi, Secretary General of PHRMAG said: “This milestone is a reflection of the collective efforts of our members, partners, and regulators who have worked together to advance patient access, foster innovation, and uphold the highest ethical standards. As we look ahead, we will continue to partner with policymakers and stakeholders to shape a future of healthcare in the region.”